Dell Backs Cancer Diagnosis Startup Ibex
Ibex develops an AI-driven diagnostic system using data from digitized glass slides and electronic medical records to reveal cancer diagnoses for tissue biopsies
Founded in 2016, Ibex develops a diagnostic system that uses computer vision, machine learning, and electronic medical records to confirm cancer diagnoses of tissue biopsies. Ibex’s technology does not replace the doctor, it just gives another opinion that can minimize the risk of human error, Ibex co-founder and CEO Joseph Mossel, said in a phone interview with Calcalist Sunday. “It is like an insurance policy that helps doctors sleep at night,” he added.
Using the secured funding, the company also intends to expand its diagnostic offering to additional types of cancer, including breast cancer and gastrointestinal cancer.